Why the study?
Implementation of practice guidelines in ACS treatment remains challenging, and a nationwide registry can provide more granular data than health insurance databases.
Population
3600 ACS patients admitted within 24 hours of symptom onset across 41 sites in Taiwan
Design
Prospective nationwide multi-center registry
Follow-up
12 months for main study, up to 20 years in extended study
Key result
The T-FORMOSA prospective registry will evaluate the implementation of guideline-directed medical therapies and 1-year clinical outcomes among 3,600 patients with acute coronary syndrome in Taiwan.
Authors
Loading...
The T-FORMOSA registry is designed to evaluate the implementation of guideline-directed medical therapies and identify prognostic predictors for 1-year outcomes in a nationwide cohort of ACS patients in Taiwan.
Observational (n=3,600)
Yes
The T-FORMOSA registry is designed to evaluate the implementation of guideline-directed medical therapies and identify prognostic predictors for 1-year outcomes in a nationwide cohort of ACS patients in Taiwan.
Chao et al. (2023) conducted an observational in Acute coronary syndrome (n=3,600). Guideline-directed medical therapies was evaluated on Degree of guideline-directed medical therapies and prognostic predictors associated with 1-year composite outcomes (death, myocardial infarction, stroke, and unplanned coronary revascularization). The T-FORMOSA prospective registry will evaluate the implementation of guideline-directed medical therapies and 1-year clinical outcomes among 3,600 patients with acute coronary syndrome in Taiwan.